Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.02 USD
−2.20 M USD
0.00 USD
3.45 M
About XORTX THERAPEUTICS INC
Sector
CEO
Allen Warren Davidoff
Headquarters
Calgary
Website
Founded
2011
FIGI
BBG00KVK0YG4
XORTX Therapeutics, Inc. is a biopharmaceutical company. The firm engages in development and commercialization of innovative therapies. It focuses on drug therapies for rare orphan disease indications such as polycystic kidney disease, and the treatment of health consequences caused by chronic high serum uric acid or hyperuricemia, including Type 2 Diabetic Nephropathy, cardiovascular disease, and diabetes. The company was founded by Allen Davidoff on May 31, 2011 and is headquartered in Calgary, Canada.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of XRTX is 1.21 USD — it has increased by 2.54% in the past 24 hours. Watch XORTX Therapeutics Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange XORTX Therapeutics Inc. stocks are traded under the ticker XRTX.
XRTX stock has fallen by −8.33% compared to the previous week, the month change is a −21.70% fall, over the last year XORTX Therapeutics Inc. has showed a −54.17% decrease.
XRTX reached its all-time high on Nov 4, 2021 with the price of 53.02 USD, and its all-time low was 1.09 USD and was reached on Aug 27, 2024. View more price dynamics on XRTX chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
XRTX stock is 10.43% volatile and has beta coefficient of 1.11. Track XORTX Therapeutics Inc. stock price on the chart and check out the list of the most volatile stocks — is XORTX Therapeutics Inc. there?
Today XORTX Therapeutics Inc. has the market capitalization of 4.64 M, it has decreased by −6.93% over the last week.
Yes, you can track XORTX Therapeutics Inc. financials in yearly and quarterly reports right on TradingView.
XORTX Therapeutics Inc. is going to release the next earnings report on Apr 30, 2025. Keep track of upcoming events with our Earnings Calendar.
XRTX net income for the last quarter is −591.73 K USD, while the quarter before that showed 170.03 K USD of net income which accounts for −448.02% change. Track more XORTX Therapeutics Inc. financial stats to get the full picture.
No, XRTX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 29, 2024, the company has 17.00 employees. See our rating of the largest employees — is XORTX Therapeutics Inc. on this list?
Like other stocks, XRTX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade XORTX Therapeutics Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So XORTX Therapeutics Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating XORTX Therapeutics Inc. stock shows the strong sell signal. See more of XORTX Therapeutics Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.